why choose us

First received: October 17, 2022

Clinical Trial: mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gestational Diabetes

Study Type: INTERVENTIONAL


Official Title: Randomized Control Trial to Investigate the Effect of a Smartphone Application for Gestational Diabetes Management on Postpartum Glucose Intolerance

Brief Summary: Without intervention, approximately 70% of women diagnosed with GDM will develop type 2 diabetes mellitus in their lifetime.Abnormal results of a 2 hour oral glucose tolerance test (OGTT) performed as early as 2 days postpartum are predictive of impaired glucose tolerance 1 year postpartum.The investigators hypothesize that use of the Malama smartphone application to optimize antenatal glycemic control will result in lower incidence of postpartum glucose intolerance, which may decrease long term risk of…

Read more